Does faecal diversion induce clinical response for Crohn's disease of the colorectum?

被引：0
|
作者：
Lightner, A. [1 ]
Buhulaigah, H. [2 ]
Zaghiyan, K. [2 ]
Vaidya, P. [1 ]
Regueiro, M. [1 ]
Fleshner, P. [2 ]
机构：
[1] Cleveland Clin, Dept Colorectal Surg, Cleveland, OH 44106 USA
[2] Cedars Sinai, Colon & Rectal Surg, Cleveland, OH USA
来源：
JOURNAL OF CROHNS & COLITIS | 2020年 / 14卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P514
引用
收藏
页码：S445 / S446
页数：2
相关论文
共 50 条
  • [21] Coherin™ peptides induce clinical response and remission in patients with active Crohn's disease
    Lichtenstein, GR
    Jacoby, HI
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2002, 97 (09): : S250 - S251
  • [22] Systematic review with meta-analysis: faecal diversion for management of perianal Crohn's disease
    Singh, S.
    Ding, N. S.
    Mathis, K. L.
    Dulai, P. S.
    Farrell, A. M.
    Pemberton, J. H.
    Hart, A. L.
    Sandborn, W. J.
    Loftus, E. V., Jr.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2015, 42 (07) : 783 - 792
  • [23] Diagnostic accuracy of faecal calprotectin in Crohn's disease - Does disease location matter?
    Simon, E.
    Wardle, R.
    Thi, A. A.
    Eldridge, J.
    Samuel, S.
    Moran, G.
    JOURNAL OF CROHNS & COLITIS, 2017, 11 : S141 - S142
  • [24] Letter: faecal diversion for severe perianal Crohn's disease - practical issues. Authors' reply
    Singh, S.
    Ding, N. S.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2015, 42 (10) : 1237 - 1237
  • [25] The clinical value of faecal calprotectin and lactoferrin measurement in postoperative Crohn's disease
    Yamamoto, Takayuki
    UNITED EUROPEAN GASTROENTEROLOGY JOURNAL, 2015, 3 (01) : 5 - 10
  • [26] Does faecal calprotectin predict risk of relapse in Crohn's disease patients lacking objective clinical evidence of inflammatory disease activity?
    Watts, David A.
    Anderson, Norman
    Brydon, Gordon
    Satsangi, Jack
    Ghosh, Subrata
    GASTROENTEROLOGY, 2006, 130 (04) : A211 - A211
  • [27] 'Temporary' faecal diversion in refractory Crohn's Disease: too good to be true? A retrospective, single centre analysis
    Alliet, B.
    Bislenghi, G.
    Vermeire, S.
    Sabino, J. P. Guedelha
    Ferrante, M.
    D'Hoore, A.
    Verstockt, B.
    JOURNAL OF CROHNS & COLITIS, 2025, 19 : i1584 - i1584
  • [28] Temporary faecal diversion in ileocolic resection for Crohn's disease: is there an impact on long-term surgical recurrence?
    Bolckmans, R.
    Singh, S.
    Ratnatunga, K.
    Wickramasinghe, D.
    Sahnan, K.
    Adegbola, S.
    Kalman, D.
    Jones, H.
    Travis, S.
    Warusavitarne, J.
    Myrelid, P.
    George, B.
    COLORECTAL DISEASE, 2020, 22 (04) : 430 - 438
  • [29] CLINICAL PREDICTORS OF VEDOLIZUMAB RESPONSE IN CROHN'S DISEASE
    Saravanapavan, Hajeena
    Sebepos-Rogers, Gregory
    Fragkos, Konstantinos
    Barragry, John
    Koo, Hui Fen
    Ko, Ho Juen
    Parisi, Ioanna
    Seward, Edward
    McCartney, Sara
    Bloom, Stuart
    Mehta, Shameer
    Rahman, Farooq
    GUT, 2021, 70 : A84 - A85
  • [30] Does faecal Calprotectin help differentiate inflammatory from fibrous stenosis in Crohn's disease?
    Ben Farhat, E.
    Sabbah, M.
    Ben Abid, M.
    Bibani, N.
    Bellil, N.
    Aoun, K.
    Bouratbine, A.
    Cargouri, D.
    JOURNAL OF CROHNS & COLITIS, 2021, 15 : S277 - S278
12345